Master Blood Transfusion MCQs: Coagulation & Hematology

30 clinical MCQs in Blood Transfusion. Which coagulation factor is deficient in Hemophilia A?

Questions, Answers & Explanations

  1. Q1. Which coagulation factor is deficient in Hemophilia A?

    Answer: Factor VIII

    Explanation: Hemophilia A = Factor VIII deficiency; Hemophilia B = Factor IX deficiency (Christmas disease).

  2. Q2. Most common cause of prolonged PT with normal aPTT?

    Answer: Factor VII deficiency

    Explanation: Factor VII is only in the extrinsic pathway (measured by PT); its deficiency prolongs PT while leaving aPTT normal.

  3. Q3. PT 45s, aPTT 65s (both prolonged) — most likely cause?

    Answer: Liver disease

    Explanation: Liver disease impairs synthesis of multiple coagulation factors, prolonging both pathways.

  4. Q4. Blood product for thrombocytopenia with active bleeding?

    Answer: Platelet concentrate

    Explanation: Thrombocytopenia = low platelets; replacing platelets directly addresses the bleeding cause.

  5. Q5. The crossmatch test primarily detects?

    Answer: All of the above

    Explanation: The crossmatch detects any antibody-antigen reaction between donor RBCs and recipient serum.

  6. Q6. Emergency transfusion, blood type unknown — give?

    Answer: O negative RBCs

    Explanation: O negative is the universal donor — no A, B, or Rh antigens to trigger reactions.

  7. Q7. Cryoprecipitate contains high concentrations of all EXCEPT?

    Answer: Factor IX

    Explanation: Cryo contains: fibrinogen, Factor VIII, Factor XIII, vWF, and fibronectin. Factor IX is NOT in cryoprecipitate.

  8. Q8. Positive direct antiglobulin test (DAT) indicates?

    Answer: Antibodies bound to patient's RBCs

    Explanation: DAT detects IgG or complement already coating the patient's own RBCs in vivo.

  9. Q9. Most serious immediate complication of blood transfusion?

    Answer: Acute hemolytic reaction

    Explanation: ABO-incompatible transfusion causes massive intravascular hemolysis, DIC, renal failure — rapidly fatal.

  10. Q10. Most sensitive lab test for detecting DIC?

    Answer: D-dimer

    Explanation: D-dimer is highly sensitive for DIC — elevated whenever clot formation and lysis are simultaneously occurring.

  11. Q11. Von Willebrand disease is characterized by?

    Answer: Prolonged bleeding time and aPTT

    Explanation: vWF is needed for platelet adhesion (bleeding time) and carries Factor VIII (aPTT).

  12. Q12. Mechanism of action of warfarin?

    Answer: Vitamin K antagonism

    Explanation: Warfarin inhibits Vitamin K epoxide reductase, blocking activation of factors II, VII, IX, and X.

  13. Q13. Patient on heparin — monitored using?

    Answer: aPTT

    Explanation: Heparin potentiates antithrombin III; therapeutic target is 1.5–2.5× normal aPTT.

  14. Q14. Heparin-induced thrombocytopenia (HIT) typically occurs?

    Answer: 5–10 days after starting heparin

    Explanation: HIT is immune-mediated via antibodies against heparin-PF4 complexes.

  15. Q15. Most important blood group system after ABO and Rh?

    Answer: Kell

    Explanation: Kell antigens are highly immunogenic and clinically the next most significant after ABO and Rh.

  16. Q16. Massive transfusion is defined as?

    Answer: >100% volume in 24h

    Explanation: Replacement of the entire blood volume (~5L) within 24 hours, or 10 units of RBCs.

  17. Q17. FFP:Platelets:RBCs ratio in massive transfusion protocol?

    Answer: 1:1:1

    Explanation: Evidence-based damage control resuscitation uses a balanced 1:1:1 ratio.

  18. Q18. Antithrombin III deficiency predisposes to?

    Answer: Thrombotic disorders

    Explanation: ATIII is a natural anticoagulant; its deficiency causes thrombophilia.

  19. Q19. Most common inherited bleeding disorder?

    Answer: Von Willebrand disease

    Explanation: vWD affects ~1% of the population — the most common inherited bleeding disorder worldwide.

  20. Q20. Factor V Leiden mutation causes?

    Answer: Resistance to activated protein C

    Explanation: Factor V Leiden makes Factor Va resistant to cleavage by activated Protein C, causing thrombophilia.

  21. Q21. TRALI is most commonly caused by?

    Answer: Donor antibodies against recipient leukocytes

    Explanation: Donor anti-HLA or anti-HNA antibodies activate recipient neutrophils in the lung, causing non-cardiogenic pulmonary edema within 6 hours.

  22. Q22. Shelf life of platelet concentrates at room temperature?

    Answer: 5 days

    Explanation: Stored at 20–24°C with agitation; limited to 5 days due to bacterial contamination risk.

  23. Q23. Which factor is NOT part of the intrinsic coagulation pathway?

    Answer: Factor VII

    Explanation: Factor VII belongs exclusively to the extrinsic pathway. Intrinsic: XII, XI, IX, VIII.

  24. Q24. Protein S functions as a cofactor for?

    Answer: Protein C

    Explanation: Protein S enhances activated Protein C's ability to degrade Factors Va and VIIIa.

  25. Q25. Most common cause of acquired coagulation disorder?

    Answer: Liver disease

    Explanation: The liver synthesizes nearly all coagulation factors — liver disease is the most common acquired coagulopathy globally.

  26. Q26. Leukoreduction of blood products primarily prevents?

    Answer: Febrile non-hemolytic reactions

    Explanation: Leukoreduction removes donor WBCs whose cytokines/antigens cause fever — the most common transfusion reaction.

  27. Q27. Normal platelet count range?

    Answer: 150,000–450,000/μL

  28. Q28. Which condition requires irradiated blood products?

    Answer: All of the above

    Explanation: Irradiation destroys donor T lymphocytes to prevent transfusion-associated GvHD in at-risk patients.

  29. Q29. The mixing study corrects in which condition?

    Answer: Hemophilia A

    Explanation: Mixing corrects factor deficiencies but NOT when inhibitors (antibodies against factors) are present.

  30. Q30. Post-transfusion purpura typically occurs?

    Answer: 5–10 days post-transfusion

    Explanation: Alloantibodies (usually anti-HPA-1a) destroy both donor and patient's own platelets 5–10 days post-transfusion.

View on OmpathStudy